These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 38649992)
1. Impact of perioperative low-molecular-weight heparin therapy on clinical events of elderly patients with prior coronary stents implanted > 12 months undergoing non-cardiac surgery: a randomized, placebo-controlled trial. Wang B; Su Y; Ma C; Xu L; Mao Q; Cheng W; Lu Q; Zhang Y; Wang R; Lu Y; He J; Chen S; Chen L; Li T; Gao L BMC Med; 2024 Apr; 22(1):171. PubMed ID: 38649992 [TBL] [Abstract][Full Text] [Related]
2. Impact of bridging with perioperative low-molecular-weight heparin on cardiac and bleeding outcomes of stented patients undergoing non-cardiac surgery. Capodanno D; Musumeci G; Lettieri C; Limbruno U; Senni M; Guagliumi G; Valsecchi O; Angiolillo DJ; Rossini R Thromb Haemost; 2015 Aug; 114(2):423-31. PubMed ID: 26017898 [TBL] [Abstract][Full Text] [Related]
3. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol. Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R; Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394 [TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry. Spyropoulos AC; Turpie AG; Dunn AS; Spandorfer J; Douketis J; Jacobson A; Frost FJ; J Thromb Haemost; 2006 Jun; 4(6):1246-52. PubMed ID: 16706967 [TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group. Lancet; 1996 Mar; 347(9001):561-8. PubMed ID: 8596317 [TBL] [Abstract][Full Text] [Related]
6. Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors. Bangalore S; Toklu B; Kotwal A; Volodarskiy A; Sharma S; Kirtane AJ; Feit F BMJ; 2014 Nov; 349():g6419. PubMed ID: 25389143 [TBL] [Abstract][Full Text] [Related]
7. Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery. Lewis SR; Pritchard MW; Schofield-Robinson OJ; Alderson P; Smith AF Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012584. PubMed ID: 30019463 [TBL] [Abstract][Full Text] [Related]
8. Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy. Spyropoulos AC; Frost FJ; Hurley JS; Roberts M Chest; 2004 May; 125(5):1642-50. PubMed ID: 15136371 [TBL] [Abstract][Full Text] [Related]
9. Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events. Cohen M; Demers C; Gurfinkel EP; Turpie AG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KA; Premmereur J; Bigonzi F Am J Cardiol; 1998 Sep; 82(5B):19L-24L. PubMed ID: 9737476 [TBL] [Abstract][Full Text] [Related]
10. Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery. Results of a multicentre registry. Rossini R; Musumeci G; Capodanno D; Lettieri C; Limbruno U; Tarantini G; Russo N; Calabria P; Romano M; Inashvili A; Sirbu V; Guagliumi G; Valsecchi O; Senni M; Gavazzi A; Angiolillo DJ Thromb Haemost; 2015 Feb; 113(2):272-82. PubMed ID: 25274620 [TBL] [Abstract][Full Text] [Related]